genome sequence will help in developing protection against the disease. Robert Walgate discovers that it might - but perhaps not in the most obvious ways.
LONDON, 8 August (
But is it of use to medicine, as some media reports and some scientists have hinted? Let's get some perspective. A quarter of a million cases of cholera, 3.6% of which (9135) were fatal, were reported to WHO in 1999. But those figures exclude Bangladesh, historically the prime focus of the disease, which does not report its cholera cases to WHO, and where experts estimate there are probably 400,000–600,000 cases a year and maybe 5000 ...
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and spot the effects of excipients on protein stability.
Designed to balance ease of use, cost efficiency, and reproducible data, which are critical requirements for successful high-throughput screening campaigns
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud
System strengthens Taiwan’s capabilities in protein drug discovery research
The Transferpette® pro expands the Transferpette® family, offering scientists even greater flexibility to match their pipetting preferences and workflow requirements.
